Showing 2 Abstracts.
Pediatric endocrine disorders often require diagnostic imaging, either as part of the diagnostic evaluation or for follow-up of known entities. Endocrine disorders may have central causes arising from pathological processes involving the hypothalamus and pituitary gland, or they may relate to a peripheral overproduction or underproduction of hormones in the body. Depending on the endocrinopathy, imaging with radiography, ultrasound, MRI, CT, or nuclear scintigraphy may be appropriate. This educational exhibit will provide the learner with a broad example of various pediatric endocrine disorders and discuss the demographics, clinical presentations, laboratory evaluation, diagnostic considerations, and appropriate imaging for these conditions. Cases will cover the following entities as they relate to pediatric imaging: 1) Intracranial anomalies and acquired diseases associated with endocrine disorders, including congenital anomalies (agenesis of corpus callosum, absence of septum pellucidum, ectopic posterior pituitary and disruption of pituitary stalk, Kallman syndrome) as well as acquired disorders (midline pituitary microadenoma / prolactinoma, central diabetes insipidus, intrasellar tumors, hypothalamic hamartoma, diabetic ketoacidosis); 2) Thyroid diseases, including thyroiditis, thyroid papillary carcinoma and therapy; 3) Adrenal diseases, including congenital adrenal hyperplasia, adrenal neurogenic tumors, adrenal hemorrhage, and adrenal infarction; 4) Gonadal disorders, including testicular adrenal rest tumors, stromal tumors with hormone overproduction, Mayer-Rokitansky-Kuster-Hauser syndrome; 5) Skeletal disorders, such as osteomalacia. Read More
Meeting name: SPR 2025 Annual Meeting , 2025
Authors: Shatadal Alankrit, Chapman Teresa
Keywords: Adrenal, Pituitary Abnormalities, Congenital
It is well-established and widely observed that newborn infants imaged by ultrasound may show transiently increased echogenicity of the renal pyramids within the first week of life, up to 10 days, postulated to reflect reduced excretion of urine that has been observed early in life. Over the past decade, as ultrasound technology has improved, we have observed in routine practice that many infants without renal disease manifest this echogenicity for several weeks and sometimes over a month. The aim of this study is to establish a new expected age range during which healthy infants may show hyperechogenicity of the renal pyramids using modern ultrasound equipment. Read More
Meeting name: SPR 2025 Annual Meeting , 2025
Authors: Herzog Abigal, Cuevas Christian, Mao Lu, Tutman Jeffrey, Squires Judy, Chapman Teresa